Generation of recombinant adenovirus vectors with modified fibers for altering viral tropism
- PMID: 8794325
- PMCID: PMC190731
- DOI: 10.1128/JVI.70.10.6839-6846.1996
Generation of recombinant adenovirus vectors with modified fibers for altering viral tropism
Abstract
To expand the utility of recombinant adenovirus vectors for gene therapy applications, methods to alter native viral tropism to achieve cell-specific transduction would be beneficial. To this end, we are pursuing genetic methods to alter the cell recognition domain of the adenovirus fiber. To incorporate these modified fibers into mature virions, we have developed a method based on homologous DNA recombination between two plasmids. A fiber-deleted, propagation-defective rescue plasmid has been designed for recombination with a shuttle plasmid encoding a variant fiber gene. Recombination between the two plasmids results in the derivation of recombinant viruses containing the variant fiber gene. To establish the utility of this method, we constructed a recombinant adenovirus containing a fiber gene with a silent mutation. In addition, we generated an adenovirus vector containing chimeric fibers composed of the tail and shaft domains of adenovirus serotype 5 and the knob domain of serotype 3. This modification was shown to alter the receptor recognition profile of the virus containing the fiber chimera. Thus, this two-plasmid system allows for the generation of adenovirus vectors containing variant fibers. This method provides a rapid and facile means of generating fiber-modified recombinant adenoviruses. In addition, it should be possible to use this system in the development of adenovirus vectors with modified tropism to allow cell-specific targeting.
Similar articles
-
Strategies to accomplish targeted gene delivery to muscle cells employing tropism-modified adenoviral vectors.Neuromuscul Disord. 1997 Jul;7(5):284-98. doi: 10.1016/s0960-8966(97)00053-9. Neuromuscul Disord. 1997. PMID: 9267842 Review.
-
Selective targeting of human cells by a chimeric adenovirus vector containing a modified fiber protein.J Virol. 1997 Jun;71(6):4782-90. doi: 10.1128/JVI.71.6.4782-4790.1997. J Virol. 1997. PMID: 9151872 Free PMC article.
-
Generation and selection of targeted adenoviruses embodying optimized vector properties.Virus Res. 2006 Mar;116(1-2):185-95. doi: 10.1016/j.virusres.2005.10.002. Epub 2005 Nov 15. Virus Res. 2006. PMID: 16293334
-
Generation of recombinant adenovirus using the Escherichia coli BJ5183 recombination system.Methods Mol Med. 2007;130:61-8. doi: 10.1385/1-59745-166-5:61. Methods Mol Med. 2007. PMID: 17401164
-
Approaches for generating recombinant adenovirus vectors.Adv Drug Deliv Rev. 2001 Nov 19;52(3):165-76. doi: 10.1016/s0169-409x(01)00215-0. Adv Drug Deliv Rev. 2001. PMID: 11718941 Review.
Cited by
-
CD40-targeted adenoviral cancer vaccines: the long and winding road to the clinic.J Gene Med. 2012 Jun;14(6):416-27. doi: 10.1002/jgm.1648. J Gene Med. 2012. PMID: 22228547 Free PMC article. Review.
-
Native and engineered tropism of vectors derived from a rare species D adenovirus serotype 43.Oncotarget. 2016 Aug 16;7(33):53414-53429. doi: 10.18632/oncotarget.10800. Oncotarget. 2016. PMID: 27462785 Free PMC article.
-
Spacers increase the accessibility of peptide ligands linked to the carboxyl terminus of adenovirus minor capsid protein IX.J Virol. 2004 Apr;78(7):3470-9. doi: 10.1128/jvi.78.7.3470-3479.2004. J Virol. 2004. PMID: 15016870 Free PMC article.
-
Adenovirus vectors for gene therapy, vaccination and cancer gene therapy.Curr Gene Ther. 2013 Dec;13(6):421-33. doi: 10.2174/1566523213666131125095046. Curr Gene Ther. 2013. PMID: 24279313 Free PMC article. Review.
-
Retargeting adenoviruses for therapeutic applications and vaccines.FEBS Lett. 2020 Jun;594(12):1918-1946. doi: 10.1002/1873-3468.13731. Epub 2020 Feb 3. FEBS Lett. 2020. PMID: 31944286 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources